(VIDEO) FDA: The current and potential disposition of cannabis products

Claire (Perry) Strofield our consultant managing the role
Posting date: 24/03/2022

Watch the recording of the live webinar hosted by Zubler Lawer where the panel looks at the current and potential disposition of the FDA in relation to subjects such as Delta 8, hemp as opposed to CBD isolate, and PMTA applications in relation to vape pens.

FDA Enforcement: Coming Soon to a Cannabis Operation Near You!

March 10th 2022

In this live webinar hosted by Zuber Lawler and Proclinical, our panel of industry experts discuss the where the FDA currently stands on medical cannabis products and how this might change in the future. The panel also take a look at lessons from previously approved products containing cannabis.

Claire Perry, Senior Partner at Proclinical Executive (Moderator)


Grace Pan, Partner at Zuber Lawler

Dr. Sud Agarwal, Chief Executive Officer at CANNVALATE

Jimmy Castillo, Chief Science Officer at Jenny's Rose

Marc Sanchez, Founder at Contract In-House Counsel and Consultants, LLC